Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative condition characterized by clinical decline in memory and other cognitive functions. A classic AD neuropathological hallmark includes the accumulation of amyloid-β (Aβ) plaques, which may precede onset of clinical symptoms by over a decade....

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Matthew K., Sullivan, Debra K., Keller, Jessica E., Burns, Jeffrey M., Swerdlow, Russell H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243383/
https://www.ncbi.nlm.nih.gov/pubmed/35784855
http://dx.doi.org/10.3389/fnins.2022.899612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243383/
https://www.ncbi.nlm.nih.gov/pubmed/35784855
http://dx.doi.org/10.3389/fnins.2022.899612

Ejemplares similares